Zoetis Australia Research and Manufacturing Pty Ltd - Betrola Investments Pty Ltd (including Jurox Pty Ltd)

Acquirer(s)

  • Zoetis Australia Research and Manufacturing Pty Ltd

Target(s)

  • Betrola Investments Pty Ltd (including Jurox Pty Ltd)

Summary

Zoetis Australia Research and Manufacturing Pty Ltd, a wholly owned subsidiary of Zoetis Inc. (Zoetis), proposes to acquire Betrola Investments Pty Ltd, including its wholly owned subsidiary, Jurox Pty Ltd (Jurox) (the Proposed Acquisition).

Zoetis and Jurox both operate globally. In Australia, they are involved in the development, manufacture and marketing of animal health products for companion animals and livestock.

The ACCC commenced its public review of the Proposed Acquisition on 30 September 2021.

On 17 February 2022, the ACCC published a Statement of Issues outlining preliminary competition concerns in relation to the Proposed Acquisition.

On 11 August 2022, the ACCC commenced market consultation on a draft proposed section 87B undertaking.

On 15 September 2022, the ACCC decided to not oppose Zoetis' proposed acquisition of Jurox, subject to the ACCC accepting a court-enforceable undertaking from Zoetis to divest Jurox's teat sealant and intramammary antibiotic products.

Market definition

The ACCC will publish a Public Competition Assessment in due course.

Competition analysis

The ACCC will publish a Public Competition Assessment in due course.

Market inquiries

Document title Date

Statement of issues

Public competition assessment

Timeline

DateEvent
30/09/2021ACCC commenced informal review under the Informal Merger Review Process Guidelines.
22/10/2021Closing date for submissions.
28/10/2021ACCC is awaiting information from the parties. Former provisional date for announcement of ACCC's findings (16 December) is delayed.
03/11/2021ACCC received information from parties.
06/12/2021ACCC is awaiting information from the parties. Former proposed date for announcement of ACCC's findings (3 February 2022) is delayed.
15/12/2021ACCC received information from parties.
17/02/2022ACCC published a Statement of Issues outlining preliminary competition concerns.
11/03/2022Closing date for submissions relating to Statement of Issues.
13/04/2022ACCC is awaiting information from the parties. Former proposed date for announcement of ACCC's findings (28 April) is delayed.
11/08/2022ACCC commenced market consultation on proposed s87B undertaking.
25/08/2022Closing date for submissions relating to the proposed s87B undertaking.
15/09/2022ACCC announced it would not oppose the proposed acquisition, subject to a section 87B undertaking accepted by the ACCC.